NCT07467772 2026-03-12Ph 2 Elacestrant in ER Positive Uterine SarcomasDana-Farber Cancer InstitutePhase 2 Not yet recruiting30 enrolled
NCT07089992 2025-12-16A Study of Pembrolizumab in People With Ultra-Rare SarcomasMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting32 enrolled
NCT06683846 2025-08-24Ivonescimab in the Treatment of Multiple Advanced TumorsFudan UniversityPhase 2 Recruiting400 enrolled